References
- Ceriello A, Gavin JR 3rd, Boulton AJM, Blickstead R, McGill M, Raz I, et al. The Berlin declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help? Diabetes Res Clin Pract. 2018; 139:392–9.
- Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016; 9:504–12.
- Lambert M. ADA releases revisions to recommendations for standards of medical care in diabetes. Am Fam Physician. 2012; 85:514–5.
- Higgins GT, Khan J, Pearce IA. Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies? Acta Ophthalmol Scand. 2007; 85:772–6.
- Feldman AL, Griffin SJ, Ahern AL, Long GH, Weinehall L, Fhärm E, et al. Impact of weight maintenance and loss on diabetes risk and burden: a population-based study in 33,184 participants. BMC Public Health. 2017; 17:170. 10.1186/s12889-017-4081-6
- Hua X, Lung TW, Palmer A, Si L, Herman WH, Clarke P. How consistent is the relationship between improved glucose control and modelled health outcomes for people with type 2 diabetes mellitus? a systematic review. Pharmacoeconomics. 2017; 35:319–29.
- Tkáč I. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: overview and metaanalysis of five trials. Diabetes Res Clin Pract. 2009; 86 (Suppl 1):S57–62.
- Tandon N, Ali MK, Narayan KM. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Am J Cardiovasc Drugs. 2012; 12:7–22.
- Al-Rifai RH, Pearson F, Crichley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS One. 2017; 12:e0187967. doi: 10.1371/journal.pone.0187967
- Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GEMH, Sandbæk A, van den Donk M, et al. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. Health Technol Assess. 2016; 20:1–86.
- Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012; 35:2650–64.
- Dorji T, Lhamo P, Tshering T, Zangmo L, Choden L, Choden D, Namgyal K. Glycemic control, medication adherence, and injection practices among diabetic patients treated in the 3 tertiary referral hospitals in Bhutan: a call for more action. Asian Biomed (Res Rev News). 2018; 12:27–33.